AbbVie Inc.
ABBVLast close · Oct 16, 2026285.42+2.02 (+0.71%)
Market cap$504.4B
Of the 85 managers this site tracks, 8 held AbbVie (ABBV) at the end of Q3 2026, their latest 13Fs. The largest position by value was Torray's, $20.8M; Mairs & Power's ($11.2M) and David Katz's ($8.9M) follow. No Schedule 13D or 13G is on file for ABBV from the activists and large holders the site follows.
Superinvestors holding ABBV
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Torray | Torray Investment Partners LLC | Q2 2026 | 82,602 | $20.8M |
| Mairs & Power | Mairs & Power Inc | Q2 2026 | 44,702 | $11.2M |
| David Katz | Matrix Asset Advisors Inc | Q3 2026 | 33,896 | $8.9M |
| Thomas Russo | Gardner Russo & Quinn LLC | Q2 2026 | 12,410 | $3.1M |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 11,775 | $3.0M |
| Jensen | Jensen Investment Management Inc | Q2 2026 | 11,064 | $2.8M |
| Dodge & Cox | Dodge & Cox | Q2 2026 | 10,393 | $2.6M |
| Bill Nygren | Harris Associates L P | Q2 2026 | 2,420 | $608,969 |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.